Allergan plc (NYSE: AGN) is a large market cap stock with a market cap of 93527.37. It is in the Drugs – Generic industry and sector Healthcare, with a current P/E of *TBA, a forward P/E of 13.83 and EPS of -6.14. At a stock price of 235.71 (-0.03%) it has a dividend yield of *TBA.
EPS growth for the last five years have been -50.40%, more recently this last year it has grown by 23.00%. The next year growth is going to be about 21.77% and more long-term 13.49% after five years. EPS growth quarter over quarter is 9.70%. Sales growth for the past five years have been 33.40% and sales growth quarter over quarter is 1.50%.
For performance, Allergan plc the past week has seen a gain of -0.87%. For the last month performance for Allergan plc is -1.43%. While the last quarter is -0.97% and half year, -2.20%. Finally for the year, performance is -13.62%.
The 52-week high for Allergan plc, is at -26.95%, and for the 52-week low it comes to a value of 20.57%. The 20-day simple moving average is -3.70% and -7.79% for the 200-day simple moving average.
Volatility for the week is at 2.22%, and for the month it is 2.05%. Allergan plc, has a target price of 299.06.
In terms of debt, long term debt/equity is 0.52, and for total debt/equity Allergan plc has 0.56. The gross margin is 78.70%, while operating margin is -16.50%, the profit margin is 27.00%. The current ratio is 1 and the quick ratio is 0.9.
Insider ownership is at 0.10%, with instituitional ownership at 87.50%. Allergan plc has a payout ratio of 0.00%. With the total shares outstanding coming to 396.79. The shares float is 395.29, with the float short at 2.09%, with short ratio coming to 2.74.
In terms of returns, the return on assets see Allergan plc, get 3.00%, with its returns on investment at -1.30%. Return on equity is 5.70%. So will the investors see the target price of 299.06, reached soon?
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.